Here are 13 key notes on orthopedic and spine device companies from the past week.
Medtronic landed No. 21 and Stryker claimed the No. 41 spot on the list of Bloomberg's "The 50 Largest Stashes of Cash Companies Keep Overseas."
Zimmer Biomet resolved the FDA's June 3, 2015, Warning Letter, regarding manufacturing issues at its Zhejiang, China manufacturing facility.
CMS issued an ICD-10 code for radiolucent porous interbody fusion devices, which covers Atlanta-based Vertera Spine's Cohere Cervical Interbody Fusion Device.
Amedica reported preliminary revenue of $3.6 million in the fourth quarter of 2016.
Tampa, Fla.-based PanMed U.S. unveiled its CurvePlus kyphoplasty device.
General Electric's GE Additive partnered with Stryker to enhance the orthopedic device company's global supply chain operations.
John Sherman, MD, used Anchor Orthopedics' AnchorKnot Tissue Approximation Kit to perform a herniated disc repair at Edina, Minn.-based Twin Cities Orthopedics.
San Diego-based Surgery One installed Smith & Nephew's NAVIO orthopedic surgical system.
In a recent two year study, DePuy Synthes evaluated the implant fixation of the ATTUNE knee tibial base and found that it achieved stable fixation by demonstrating average micromotion of 0.17 millimeters between one and two years.
ConforMIS published its study that shows that a smaller percentage of total knee arthroplasty patients who had customized implants experienced adverse events at discharge and 90 days after discharge, compared to off-the-shelf implant TKA patients.
A study, published in Techniques in Orthopaedics, found that MiMedx Group's dehydrated human aminon/chorion membrane allografts modulated three main phases of healing, including inflammation, proliferation and remodeling.
Athens, Greece-based orthopedic surgeon Spyridon Armpis, MD, is using OrthAlign's KneeAlign to completed total knee arthroplasties in Greece.
Camber Spine Technologies created two new area sales director positions.